Clin2
NCT06273800Possibly a fitRecruiting

Chemo timing and the menstrual cycle in breast cancer

Breast Cancer

Treatments studied

Part of Cancer, Skin clinical trials.

This study tests whether the timing of chemotherapy during your menstrual cycle affects how well it works in triple-negative breast cancer. Women with regular periods who are about to start chemo before surgery may be eligible.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
100 people
Ages
18 years to 59 years
Study type
Interventional

Who can take part

  • You are female and younger than 60.
  • You have just been diagnosed with triple-negative breast cancer that is stage I, II, or III, or cancer that came back in the same area (but not spread far away).
  • You have not started any breast cancer treatment yet (no chemo, hormone therapy, or targeted therapy).
  • You have regular monthly periods (not on hormonal birth control like the pill, IUD, or implant).
  • You are willing to receive chemotherapy before surgery (neoadjuvant).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06681064Recruiting
Tracking breast cancer changes during pre-surgery treatment

This study looks at how breast cancer changes while you are receiving chemotherapy or targeted therapy before surgery. The goal is to better understand which treatments work best for different types of breast cancer.

London
NCT07743632Not yet recruiting· Phase 2
Chemoimmunotherapy before surgery for triple-negative breast cancer

This study tests a combination of chemotherapy and immunotherapy given before surgery for triple-negative breast cancer. It aims to shrink the tumor and improve outcomes. The treatment is given intravenously.

NCT07423611Not yet recruiting· Phase 2
Using a blood test to skip chemo in breast cancer

This trial tests if women with a common type of breast cancer (HR+/HER2-) can safely skip chemotherapy after surgery by taking targeted medication (ribociclib) plus hormone therapy. A special blood test called ctDNA helps doctors decide if chemo isn't needed.

Shanghai, Shanghai Municipality
NCT04540692Recruiting· Phase 3
Testing chemotherapy timing for certain HER2-negative breast cancers

This Phase 3 trial studies different ways of giving common chemotherapy drugs (anthracyclines and taxanes) for locally advanced breast cancer that is HER2-negative. It aims to see which order or “sequencing” may work better for people like you.

Cachoeiro de Itapemirim, Espírito Santo
NCT06455904Recruiting
Cycling exercise during chemo for breast cancer

This trial tests whether a special cycling exercise program during chemotherapy can help women with breast cancer. It is for patients who are about to start a common type of chemotherapy and want to add physical activity to their treatment plan.

Colmar
NCT04138719Recruiting· Phase 2
Test two chemotherapy combos before breast surgery for triple-negative cancer

This trial compares two different chemotherapy combinations given before surgery (neoadjuvant therapy) for people with triple-negative breast cancer. It looks to see which drug combination works better to control the cancer before and around the time of the operation.

Shijiazhuang, Hebei

Hear when a new Breast cancer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.